A novel drug reduces the monthly frequency of seizure in adults with focal epilepsy Post author: Post published:October 11, 2023 Post category:uncategorized The effect of a novel Kv7.2/Kv7.3 potassium channel opener XEN1101 in reducing monthly seizure frequency in adults. You Might Also Like Pregnancy history could unlock early interventions for women’s heart health February 28, 2024 Study looks at ways to more accurately predict when migraine attack will occur January 24, 2024 Clonal hematopoiesis drives femoral atherosclerosis in middle-aged adults September 2, 2024